FIELD: medicine. SUBSTANCE: method involves intra-amnially introducing 75-35 ml of physiological salt solution into the uterine under ultrasonic control. 3-5 ml of the introduce solution is sucked and mixed with enzaprost F2a. Intrauterine instillation of the mixture is carried out. EFFECT: reduced risk of traumatic complications related to pregnancy interruption.
| Title | Year | Author | Number | 
|---|---|---|---|
| PRECLINICAL METHOD FOR DIAGNOSING THE CASES OF GESTOSIS | 1998 | 
 | RU2135999C1 | 
| METHOD FOR PREVENTING INFLAMMATORY COMPLICATIONS AFTER ARTIFICIAL INTERRUPTION OF PREGNANCY IN TRIMESTER I | 2000 | 
 | RU2193408C2 | 
| METHOD FOR DIAGNOSING SEVERE GESTOSIS FORMS | 2003 | 
 | RU2259568C2 | 
| ULTRASONIC DIAGNOSIS METHOD FOR DIAGNOSING POSTPARTUM DEFECTS OF RECTUM SPHINCTER | 2002 | 
 | RU2226984C2 | 
| METHOD FOR UMBILICAL VESSEL COAGULATION IN FOETUS WITH ACARDIA IN REVERSED ARTERIAL PERFUSION SYNDROME | 2014 | 
 | RU2562600C1 | 
| METHOD FOR PREPARING AND CONDUCTING THE PREGNANCY IN WOMEN WITH HERPES VIRAL INFECTION | 2005 | 
 | RU2283141C1 | 
| METHOD FOR DETECTING BLOOD LOSS AT CAESAREAN OPERATION | 2002 | 
 | RU2239351C2 | 
| METHOD FOR PREDICTING GESTATION ARTERIAL HYPERTENSION DEVELOPMENT | 1996 | 
 | RU2122207C1 | 
| METHOD FOR DIAGNOSTICS OF SUBCLINICAL INTRAUTERINE INFECTION IN WOMEN IN THE II TRIMESTER OF PREGNANCY | 2021 | 
 | RU2771877C1 | 
| METHOD OF DETERMINING EFFICIENCY OF IMMUNOCYTOTHERAPY IN PATIENTS WITH OPERABLE TOXEMIA OF PREGNANCY | 1996 | 
 | RU2105311C1 | 
Authors
Dates
1999-01-10—Published
1995-10-20—Filed